mosunetuzumab,prednisone
roche
['dlbcl', 'prednisone', 'mosunetuzumab']
mosunetuzumab in elderly unfit dlbcl in 1l setting: n=54, majority were older than 80 years, 19% dhl, 56% stage 3-4, non-gcb &gt;50%, crs 26%, no grade 3 crs, orr 56%, cr 43%, rr were lower in bulky disease, 1-yr pfs 38%, 1-year os 75%. #ash22 